Biomaterials that act as both protein delivery vehicle and scaffold can improve the safety and efficacy of bone morphogenetic protein-2 (BMP-2) for clinical applications. However, the optimal scaffold characteristics are not known. The osteoinductive and osteoconductive capacity of a fixed electrically charged surface is thus far unexplored. Therefore, in this study, we aim to investigate the effect of different electrical states on BMP-2-induced bone formation in oligo[(polyethylene glycol) fumarate] (OPF) hydrogels. Neutral, negatively, or positively charged scaffolds were fabricated using unmodified OPF (neutral charge), sodium methacrylate crosslinked OPF (negative charge), or [2-(methacryloyloxy) ethyl] trimethylammonium chloride crosslinked OPF (positive charge), respectively. To allow investigation of surface charge for different BMP-2 release rates, three BMP-2 release profiles were generated by protein encapsulation into poly(lactic-co-glycolic acid) microspheres and/or adsorption on the OPF composite. Release of radiolabeled 125I-BMP-2 was analyzed in vitro and in vivo and bone formation was assessed after 9 weeks of subcutaneous implantation in rats. Negatively charged OPF generated significantly more bone formation compared with neutral and positively charged OPF. This effect was seen for all three loading methods and subsequent BMP-2 release profiles. Along with charge modifications, a more sustained release of BMP-2 improved overall bone formation in OPF composites. Overall, this study clearly shows that negative charge enhances bone formation compared with neutral and positive charge in OPF composites.
Impact Statement
Biomaterials can play a dual role in bone regeneration: they enable local sustained delivery of growth factors, such as bone morphogenetic protein-2 (BMP-2), while they provide structural support as scaffold. By better imitating the properties of native bone tissue, scaffolds may be both osteoconductive and osteoinductive. The latter can be achieved by modifying the electrical charge of the surface. The present work uses tunable oligo[(polyethylene glycol) fumarate] hydrogel and demonstrates that negative charge enhances BMP-2-induced bone formation compared with neutral or positive charge. Altogether, this indicates that tissue-specific surface charge modifications of biomaterials hold great promise in the field of tissue regeneration.
Get full access to this article
View all access options for this article.
References
1.
SeehermanH., LiR., and WozneyJ.A review of preclinical program development for evaluating injectable carriers for osteogenic factors. J Bone Joint Surg Am, 85(Suppl. 3), 96, 2003.
2.
PutneyS.D., and BurkeP.A.Improving protein therapeutics with sustained-release formulations. Nat Biotechnol, 16, 153, 1998.
3.
Rodríguez-ÉvoraM., DelgadoA., ReyesR., et al.Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-betaTCP concentric system in a critical size defect in rats. Eur J Pharm Sci, 49, 873, 2013.
4.
YamamotoM., TakahashiY., and TabataY.Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials, 24, 4375, 2003.
5.
YamamotoM., TabataY., and IkadaY.Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. J Biomater Sci Polym Ed, 9, 439, 1998.
6.
FurthM.E., AtalaA., and Van DykeM.E.Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials, 28, 5068, 2007.
7.
LangerR., CimaL.G., TamadaJ.A., and WintermantelE.Future directions in biomaterials. Biomaterials, 11, 738, 1990.
8.
ChoudharyS., HaberstrohK.M., and WebsterT.J.Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng, 13, 1421, 2007.
9.
LuJ., RaoM.P., MacDonaldN.C., KhangD., and WebsterT.J.Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater, 4, 192, 2008.
10.
ZhangY.M., Bataillon-LinezP., HuangP., et al.Surface analyses of micro-arc oxidized and hydrothermally treated titanium and effect on osteoblast behavior. J Biomed Mater Res A, 68, 383, 2004.
11.
FukadaE., and YasudaI.On the piezoelectric effect of bone. J Phys Soc Jpn, 12, 1158, 1957.
12.
YasudaI.Electrical callus and callus formation by electret. Clin Orthop Relat Res, 124, 53, 1977.
SaitoA., SuzukiY., OgataS.I., OhtsukiC., and TaniharaM.Accelerated bone repair with the use of a synthetic BMP‐2‐derived peptide and bone‐marrow stromal cells. J Biomed Mater Res A, 72a, 77, 2005.
15.
SalinasC.N., and AnsethK.S.The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials, 29, 2370, 2008.
16.
KingT.G., PrestonM.E., MurphyB.J.M., and CannellD.S.Piezoelectric ceramic actuators: a review of machinery applications. Precis Eng, 12, 131, 1990.
17.
YasudaI.Piezoelectricity of living bone. J Kyoto Pref Univ Med, 53, 325, 1953.
18.
YasudaI.The classic fundamental aspects of fracture treatment. Clin Orthop Relat Res, 124, 5, 1977.
19.
FukadaE.Piezoelectric properties of organic polymers. Ann N Y Acad Sci, 238, 7, 1974.
20.
BassettC.A.L., PawlukR.J., and BeckerR.O.Effects of electric currents on bone in vivo. Nature, 204, 652, 1964.
21.
ParkJ.B., von RecumA.F., KennerG.H., KellyB.J., CoffeenW.W., and GretherM.F.Piezoelectric ceramic implants: a feasibility study. J Biomed Mater Res, 14, 269, 1980.
22.
FengJ., YuanH., and ZhangX.Promotion of osteogenesis by a piezoelectric biological ceramic. Biomaterials, 18, 1531, 1997.
23.
IkadaY., ShikinamiY., HaraY., TagawaM., and FukadaE.Enhancement of bone formation by drawn poly(L-lactide). J Biomed Mater Res, 30, 553, 1996.
24.
InoueS., OhashiT., YasudaI., and FukadaE.Electret induced callus formation in the rat. Clin Orthop Relat Res, 124, 57, 1977.
25.
YamashitaK., OikawaN., and UmegakiT.Acceleration and deceleration of bone-like crystal growth on ceramic hydroxyapatite by electric poling. Chem Mater, 8, 2697, 1996.
26.
OhgakiM., KizukiT., KatsuraM., and YamashitaK.Manipulation of selective cell adhesion and growth by surface charges of electrically polarized hydroxyapatite. J Biomed Mater Res, 57, 366, 2001.
27.
NakamuraS., KobayashiT., and YamashitaK.Numerical osteobonding evaluation of electrically polarized hydroxyapatite ceramics. J Biomed Mater Res A, 68, 90, 2004.
28.
DadsetanM., PumbergerM., CasperM.E., et al.The effects of fixed electrical charge on chondrocyte behavior. Acta Biomater, 7, 2080, 2011.
29.
DadsetanM., KnightA.M., LuL., WindebankA.J., and YaszemskiM.J.Stimulation of neurite outgrowth using positively charged hydrogels. Biomaterials, 30, 3874, 2009.
30.
OlthofM.G.L., KempenD.H.R., LiuX., et al.Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel. J Tissue Eng Regen Med, 12, 1339, 2018.
31.
PodusloJ.F., CurranG.L., and BergC.T.Macromolecular permeability across the blood-nerve and blood–brain barriers. Proc Natl Acad Sci U S A, 91, 5705, 1994.
32.
KempenD.H., LuL., HefferanT.E., et al.Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials, 29, 3245, 2008.
33.
KempenD.H., LuL., ClassicK.L., et al.Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants. J Control Release, 130, 15, 2008.
34.
ShiveM.S., and AndersonJ.M.Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28, 5, 1997.
35.
DadsetanM., SzatkowskiJ.P., YaszemskiM.J., and LuL.Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering. Biomacromolecules, 8, 1702, 2007.
36.
ThiesR.S., BauduyM., AshtonB.A., KurtzbergL., WozneyJ.M., and RosenV.Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology, 130, 1318, 1992.
37.
VillanuevaA.R., and MehrL.A.Modifications of the Goldner and Gomori one-step trichrome stains for plastic-embedded thin sections of bone. Am J Med Technol, 43, 536, 1977.
38.
GruberR., WeichH.A., DullinC., and SchliephakeH.Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2. Clin Oral Implants Res, 20, 24, 2009.
39.
TazakiJ., MurataM., AkazawaT., et al.BMP-2 release and dose–response studies in hydroxyapatite and beta-tricalcium phosphate. Biomed Mater Eng, 19, 141, 2009.
40.
BodhakS., BoseS., and BandyopadhyayA.Role of surface charge and wettability on early stage mineralization and bone cell-materials interactions of polarized hydroxyapatite. Acta Biomater, 5, 2178, 2009.
41.
BodhakS., BoseS., and BandyopadhyayA.Electrically polarized HAp-coated Ti: in vitro bone cell-material interactions. Acta Biomater, 6, 641, 2010.
42.
TarafderS., BodhakS., BandyopadhyayA., and BoseS.Effect of electrical polarization and composition of biphasic calcium phosphates on early stage osteoblast interactions. J Biomed Mater Res B Appl Biomater, 97, 306, 2011.
43.
KizukiT., OhgakiM., KatsuraM., et al.Effect of bone-like layer growth from culture medium on adherence of osteoblast-like cells. Biomaterials, 24, 941, 2003.
44.
NakamuraS., KobayashiT., and YamashitaK.Extended bioactivity in the proximity of hydroxyapatite ceramic surfaces induced by polarization charges. J Biomed Mater Res, 61, 593, 2002.
45.
NakamuraM., SekijimaY., NakamuraS., KobayashiT., NiwaK., and YamashitaK.Role of blood coagulation components as intermediators of high osteoconductivity of electrically polarized hydroxyapatite. J Biomed Mater Res A, 79, 627, 2006.
46.
DaviesJ.E., CaustonB., BovellY., DavyK., and SturtC.S.The migration of osteoblasts over substrata of discrete surface charge. Biomaterials, 7, 231, 1986.
47.
FarbodK., NejadnikM.R., JansenJ.A., and LeeuwenburghS.C.Interactions between inorganic and organic phases in bone tissue as a source of inspiration for design of novel nanocomposites. Tissue Eng Part B Rev, 20, 173, 2014.
48.
ToworfeG.K., CompostoR.J., ShapiroI.M., and DucheyneP.Nucleation and growth of calcium phosphate on amine-, carboxyl- and hydroxyl-silane self-assembled monolayers. Biomaterials, 27, 631, 2006.
49.
ItohS., NakamuraS., NakamuraM., ShinomiyaK., and YamashitaK.Enhanced bone ingrowth into hydroxyapatite with interconnected pores by electrical polarization. Biomaterials, 27, 5572, 2006.
50.
HosseinkhaniH., HosseinkhaniM., KhademhosseiniA., and KobayashiH.Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release, 117, 380, 2007.
51.
HernándezA., SánchezE., SorianoI., ReyesR., DelgadoA., and ÉvoraC.Material-related effects of BMP-2 delivery systems on bone regeneration. Acta Biomater, 8, 781, 2012.
52.
TakahashiY., YamamotoM., and TabataY.Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials, 26, 4856, 2005.
53.
TakitaH., VehofJ.W., JansenJ.A., et al.Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. J Biomed Mater Res A, 71, 181, 2004.
54.
BoddeE.W., BoermanO.C., RusselF.G., MikosA.G., SpauwenP.H., and JansenJ.A.The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A, 87, 780, 2008.
55.
UludagH., D'AugustaD., GoldenJ., et al.Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res, 50, 227, 2000.
56.
van de WateringF.C., Molkenboer-KuenenJ.D., BoermanO.C., van den BeuckenJ.J., and JansenJ.A.Differential loading methods for BMP-2 within injectable calcium phosphate cement. J Control Release, 164, 283, 2012.
57.
OlthofM.G.L., LuL., TryfonidouM.A., et al.The osteoinductive effect of controlled BMP-2 release is location-dependent. Tissue Eng Part A, 25, 193, 2019.
58.
XiaZ., and TriffittJ.T.A review on macrophage responses to biomaterials. Biomed Mater, 1, R1, 2006.
59.
BaxterF.R., BowenC.R., TurnerI.G., and DentA.C.Electrically active bioceramics: a review of interfacial responses. Ann Biomed Eng, 38, 2079, 2010.
60.
PiskounovaS., GeddaL., Hulsart-BillströmG., HilbornJ., and BowdenT.Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabelling. J Tissue Eng Regen Med, 8, 821, 2014.
61.
RuhéP.Q., BoermanO.C., RusselF.G., MikosA.G., SpauwenP.H., and JansenJ.A.In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med, 17, 919, 2006.
62.
WooB.H., FinkB.F., PageR., et al.Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res, 18, 1747, 2001.
63.
YamamotoM., IkadaY., and TabataY.Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed, 12, 77, 2001.
64.
OlthofM.G.L., TryfonidouM.A., DadsetanM., et al.In vitro and in vivo correlation of bone morphogenetic protein-2 release profiles from complex delivery vehicles. Tissue Eng Part C Methods, 24, 379, 2018.
65.
LuginbuehlV., MeinelL., MerkleH.P., and GanderB.Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm, 58, 197, 2004.
66.
PatelZ.S., YamamotoM., UedaH., TabataY., and MikosA.G.Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater, 4, 1126, 2008.
67.
Louis-UgboJ., KimH.S., BodenS.D., et al.Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J Orthop Res, 20, 1050, 2002.
68.
ReyesR., DelgadoA., SánchezE., FernándezA., HernándezA., and EvoraC.Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFbeta1 from a bilayered alginate-PLGA scaffold. J Tissue Eng Regen med, 8, 521, 2014.
69.
ReyesR., DelgadoA., SolisR., et al.Cartilage repair by local delivery of transforming growth factor-beta1 or bone morphogenetic protein-2 from a novel, segmented polyurethane/polylactic-co-glycolic bilayered scaffold. J Biomed Mater Res A, 102, 1110, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
